Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMC 423866)

Published in J Clin Invest on August 01, 1985

Authors

D W Rowe, J R Shapiro, M Poirier, S Schlesinger

Articles citing this

Tracking COL1A1 RNA in osteogenesis imperfecta. splice-defective transcripts initiate transport from the gene but are retained within the SC35 domain. J Cell Biol (2000) 1.74

Collagen defects in lethal perinatal osteogenesis imperfecta. Biochem J (1986) 1.62

Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. J Clin Invest (1990) 1.61

Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet (1996) 1.59

Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet (1994) 1.51

Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet (1992) 1.35

Laparoscopic incisional hernia repair: a review of the literature. Hernia (2006) 1.22

Severe osteogenesis imperfecta in cyclophilin B-deficient mice. PLoS Genet (2009) 1.12

Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta. J Clin Invest (1996) 1.04

Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen. J Clin Invest (1986) 0.99

Genetic disorders of collagen. J Med Genet (1987) 0.86

Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransferase. J Biol Chem (2016) 0.78

Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta. Biochem J (1989) 0.78

A scoring system for the assessment of clinical severity in osteogenesis imperfecta. J Child Orthop (2012) 0.77

Incisional hernia recurrence through genomic profiling: a pilot study. Hernia (2012) 0.76

Segregation analysis of dominant osteogenesis imperfecta in Italy. J Med Genet (1990) 0.75

Absence of mutations in the promoter of the COL1A1 gene of type I collagen in patients with osteogenesis imperfecta type I. J Med Genet (1995) 0.75

Single base pair alterations as the predominant category of mutation in type I osteogenesis imperfecta. J Med Genet (1989) 0.75

Articles cited by this

A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22

Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70

Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry (1971) 7.39

Structurally distinct collagen types. Annu Rev Biochem (1980) 6.43

A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing. Cell (1982) 4.22

Collagen polymorphism: characterization of molecules with the chain composition (alpha 1 (3)03 in human tissues. Science (1974) 3.95

Beta + thalassemia: aberrant splicing results from a single point mutation in an intron. Cell (1981) 3.51

Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. Nucleic Acids Res (1982) 3.40

The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun (1976) 3.22

Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop Relat Res (1981) 2.94

Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature (1983) 2.73

Abnormally spliced messenger RNA in erythroid cells from patients with beta+ thalassemia and monkey cells expressing a cloned beta+-thalassemic gene. Cell (1982) 2.52

Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta. J Clin Invest (1983) 2.50

Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen. Proc Natl Acad Sci U S A (1982) 2.45

Structure of a cDNA for the pro alpha 2 chain of human type I procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies structurally conserved features of the protein and the gene. Biochemistry (1983) 2.41

Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1981) 2.28

Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta. J Biol Chem (1983) 2.03

Nonsense and frameshift mutations in beta 0-thalassemia detected in cloned beta-globin genes. J Biol Chem (1981) 2.02

Human pro alpha 1(I) collagen gene structure reveals evolutionary conservation of a pattern of introns and exons. Nature (1984) 1.97

Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects Orig Artic Ser (1979) 1.85

Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta. J Clin Invest (1983) 1.71

Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta. J Biol Chem (1983) 1.71

Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta. Am J Hum Genet (1984) 1.62

Thalassemia revisited. Cell (1982) 1.58

The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem (1983) 1.52

Recovery of DNA fragments from gels by transfer to DEAE-paper in an electrophoresis chamber. Anal Biochem (1982) 1.51

beta-Thalassemia in a Kurdish Jew. Single base changes in the T-A-T-A box. J Biol Chem (1982) 1.38

Biochemical heterogeneity of osteogenesis imperfecta: New variant. Lancet (1979) 1.32

The formation of triple-helical collagen molecules from alpha-1 or alpha-2 polypeptide chains. Eur J Biochem (1969) 1.20

Osteogenesis imperfecta after the menopause. N Engl J Med (1984) 1.15

Two cloned beta thalassemia genes are associated with amber mutations at codon 39. Nucleic Acids Res (1981) 1.14

Procollagen: intermediate forms containing several types of peptide chains and non-collagen peptide extensions at NH2 and COOH ends. Proc Natl Acad Sci U S A (1974) 1.06

The mRNAs for the pro-alpha 1(I) and pro-alpha 2(I) chains of type I procollagen are translated at the same rate in normal human fibroblasts and in fibroblasts from two variants of osteogenesis imperfecta with altered steady state ratios of the two mRNAs. J Biol Chem (1983) 1.01

Regulation of collagen synthesis in fetal rat calvaria by 1,25-dihydroxyvitamin D3. J Biol Chem (1982) 0.93

Clinical and genetic patterns in osteogenesis imperfecta. Clin Orthop Relat Res (1981) 0.91

Confirmation that the type I collagen gene on chromosome 17 is COL1A1 (alpha 1(I), using a human genomic probe. Ann Hum Genet (1984) 0.90

Posttranscriptional defects in beta-globin messenger RNA metabolism in beta-thalassemia: abnormal accumulation of beta-messenger RNA precursor sequences. J Clin Invest (1981) 0.90

Osteogenesis imperfecta and Paget's disease of bone. Biochemical and morphologic studies. Arch Intern Med (1983) 0.80

Articles by these authors

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science (1989) 4.84

Formation of Sindbis virus proteins: identification of a precursor for one of the envelope proteins. J Virol (1972) 4.43

Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol (1993) 4.19

Deletion mapping of Sindbis virus DI RNAs derived from cDNAs defines the sequences essential for replication and packaging. Cell (1986) 3.89

Identification of a second glycoprotein in Sindbis virus. Virology (1972) 3.60

Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation (1997) 3.40

New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A (1998) 3.14

Evidence for specificity in the encapsidation of Sindbis virus RNAs. J Virol (1989) 2.91

Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci U S A (1975) 2.88

Correlation of procollagen mRNA levels in normal and transformed chick embryo fibroblasts with different rates of procollagen synthesis. Biochemistry (1978) 2.85

Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses. J Virol (1977) 2.83

Processing of high mannose oligosaccharides to form complex type oligosaccharides on the newly synthesized polypeptides of the vesicular stomatitis virus G protein and the IgG heavy chain. J Biol Chem (1978) 2.83

Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol (1990) 2.73

The nonglycosylated glycoprotein of vesicular stomatitis virus is temperature-sensitive and undergoes intracellular aggregation at elevated temperatures. J Biol Chem (1979) 2.70

RNAs from two independently isolated defective interfering particles of Sindbis virus contain a cellular tRNA sequence at their 5' ends. Proc Natl Acad Sci U S A (1983) 2.58

Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J Virol (1999) 2.49

Exogenous and endogenous induction of the histidine-degrading enzymes in Aerobacter aerogenes. J Biol Chem (1965) 2.49

Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci U S A (1998) 2.44

Large-molecular-weight precursors of sindbis virus proteins. J Virol (1973) 2.37

Impaired intracellular migration and altered solubility of nonglycosylated glycoproteins of vesicular stomatitis virus and Sindbis virus. J Biol Chem (1977) 2.36

Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone (2004) 2.35

Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32

Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. J Virol (1994) 2.25

Synthesis and infectivity of vesicular stomatitis virus containing nonglycosylated G protein. Cell (1978) 2.23

Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci U S A (1996) 2.18

Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone (2002) 2.12

Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A (1993) 2.07

Deletion analysis of the capsid protein of Sindbis virus: identification of the RNA binding region. J Virol (1993) 2.03

Common and distinct regions of defective-interfering RNAs of Sindbis virus. J Virol (1984) 1.96

Recombination between Sindbis virus RNAs. J Virol (1991) 1.90

Inhibition of growth of Escherichia coli and of homoserine O-transsuccinylase by alpha-methylmethionine. J Bacteriol (1967) 1.90

Translation of Sindbis virus mRNA: analysis of sequences downstream of the initiating AUG codon that enhance translation. J Virol (1996) 1.89

Translation of Sindbis virus mRNA: effects of sequences downstream of the initiating codon. J Virol (1994) 1.86

On-scene helicopter transport of patients with multiple injuries--comparison of a German and an American system. J Trauma (1992) 1.84

Mutants of Escherichia coli with an altered tyrosyl-transfer ribonucleic acid synthetase. J Bacteriol (1969) 1.82

Marfan syndrome: abnormal alpha 2 chain in type I collagen. Proc Natl Acad Sci U S A (1981) 1.78

Packaging signals in alphaviruses. J Virol (1997) 1.76

Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta. J Clin Invest (1983) 1.71

Growth of enveloped RNA viruses in a line of chinese hamster ovary cells with deficient N-acetylglucosaminyltransferase activity. J Virol (1975) 1.71

Interactions between Sindbis virus RNAs and a 68 amino acid derivative of the viral capsid protein further defines the capsid binding site. Nucleic Acids Res (1994) 1.70

Establishment and maintenance of persistent infection by Sindbis virus in BHK cells. J Virol (1980) 1.66

Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome. Proc Natl Acad Sci U S A (1991) 1.64

Temperature sensitive shut-off of alphavirus minus strand RNA synthesis maps to a nonstructural protein, nsP4. Virology (1990) 1.60

Sequence analysis of cDNA's derived from the RNA of Sindbis virions and of defective interfering particles. J Virol (1982) 1.59

Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene. Virology (1997) 1.57

Experimental obesity in man. Trans Assoc Am Physicians (1968) 1.51

Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells. J Cell Biol (1992) 1.48

Sclerosteosis: neurogenetic and pathophysiologic analysis of an American kinship. Neurology (1983) 1.47

Defective virus particles from Sindbis virus. Virology (1972) 1.44

Engineered defective interfering RNAs of Sindbis virus express bacterial chloramphenicol acetyltransferase in avian cells. Proc Natl Acad Sci U S A (1987) 1.44

Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res (1981) 1.44

Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J Virol (1997) 1.42

Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations. Hum Mutat (1998) 1.42

Nutritional hypophosphatemic rickets in a premature infant fed breast milk. N Engl J Med (1979) 1.38

Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc Natl Acad Sci U S A (1999) 1.38

Oligonucleotide mapping studies of standard and defective Sindbis virus RNA. J Virol (1979) 1.36

Studies of defective interfering RNAs of Sindbis virus with and without tRNAAsp sequences at their 5' termini. J Virol (1985) 1.36

Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res (2001) 1.35

NH2-terminal sequence of the chick proalpha1(I) chain synthesized in the reticulocyte lysate system. Evidence for a transient hydrophobic leader sequence. J Biol Chem (1979) 1.34

Decreased lysyl oxidase activity in the aneurysm-prone, mottled mouse. J Biol Chem (1977) 1.33

Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res (2001) 1.32

Visualizing levels of osteoblast differentiation by a two-color promoter-GFP strategy: Type I collagen-GFPcyan and osteocalcin-GFPtpz. Genesis (2005) 1.31

Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci U S A (1999) 1.30

The effect of oligosaccharide chains of different sizes on the maturation and physical properties of the G protein of vesicular stomatitis virus. J Biol Chem (1981) 1.29

Defective interfering passages of Sindbis virus: chemical composition, biological activity, and mode of interference. J Virol (1973) 1.29

Defective interfering passages of Sindbis virus: nature of the defective virion RNA. J Virol (1976) 1.28

Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J Bone Miner Res (1994) 1.24

Effects of 5'-terminal modifications on the biological activity of defective interfering RNAs of Sindbis virus. J Virol (1988) 1.24

Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol (1997) 1.22

Physical properties of a soluble form of the glycoprotein of vesicular stomatitis virus at neutral and acidic pH. Biochemistry (1983) 1.22

Isolation and characterization of the rat alpha 1(I) collagen promoter. Regulation by 1,25-dihydroxyvitamin D. J Biol Chem (1989) 1.21

Developmental and temperamental differences in emotion regulation in infancy. Child Dev (1995) 1.20

The effect of amino acid analogues on alkaline phosphatase formation in Escherichia coli K-12. I. Substitution of triazolealanine for histidine. J Biol Chem (1967) 1.20

A plasmid-based self-amplifying Sindbis virus vector. Hum Gene Ther (1995) 1.19

Reduction of target gene expression by a modified U1 snRNA. Mol Cell Biol (2001) 1.18

Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. J Psychopharmacol (2009) 1.18

Imidazolepropionate, a nonmetabolizable inducer for the histidine-degrading enzymes in Aerobacter aerogenes. J Biol Chem (1965) 1.17

The effect of amino acid analogues on alkaline phosphatase formation in Escherichia coli K-12. IV. Substitution of canavanine for arginine. J Biol Chem (1969) 1.16

Crystallization of Sindbis virus and its nucleocapsid. J Mol Biol (1992) 1.16

A sex-linked defect in the cross-linking of collagen and elastin associated with the mottled locus in mice. J Exp Med (1974) 1.16

Cardiovascular involvement in osteogenesis imperfecta. Circulation (1986) 1.14

Role of the striatum, cerebellum and frontal lobes in the automatization of a repeated visuomotor sequence of movements. Neuropsychologia (1998) 1.12

Pediatrician's self-evaluation of adolescent health care training, skills, and interest. J Adolesc Health Care (1986) 1.12

Transgenic expression of COL1A1-chloramphenicol acetyltransferase fusion genes in bone: differential utilization of promoter elements in vivo and in cultured cells. Mol Cell Biol (1993) 1.12

Effects of component length and of the transitions among components in multiple schedules. J Exp Anal Behav (1978) 1.12

A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand RNA viruses. Virology (1994) 1.10

Receptor tyrosine kinase expression in human bone marrow stromal cells. J Cell Physiol (1998) 1.10

Domains of virus glycoproteins. Adv Virus Res (1987) 1.10

Cell adhesion regulates pro-alpha 1(I) collagen mRNA stability and transcription in mouse fibroblasts. J Biol Chem (1991) 1.09

Formation and localization of the alkaline phosphatase of Escherichia coli. Ann N Y Acad Sci (1969) 1.09

Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology (2001) 1.09

Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. Biochem J (1991) 1.09

Achilles tendinitis and tenosynovitis. A diagnostic manifestation of familial type II hyperlipoproteinemia in children. Am J Dis Child (1974) 1.08

Col1a1-GFP transgene expression in developing incisors. Connect Tissue Res (2002) 1.07

Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction. Clin Pharmacol Ther (1975) 1.07

The formation of vesicular stomatitis virus (San Juan strain) becomes temperature-sensitive when glucose residues are retained on the oligosaccharides of the glycoprotein. J Biol Chem (1984) 1.06

Structural proteins of lactic dehydrogenase virus. Virology (1973) 1.06

Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta. J Clin Invest (1993) 1.06